Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-036-0 | CAS number: 603-35-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.5 mg/m³
- Most sensitive endpoint:
- neurotoxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 10
- Dose descriptor starting point:
- NOAEC
- Value:
- 10 mg/m³
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The worker-DNEL long-term for inhalation route - systemic is derived from the NOAEC of 10 mg/m³, obtained in the sub-acute inhalation study in dogs (M&T Chemicals, 1983) in which TPP was administered as a xylene-based aerosol. The NOAECcorr is calculated as follows: NOAECcorr = 10 mg/m³*((6 h/d)/(8 h/d))*(6.7 m³ (8h)/10 m³ (8h)) = 5 mg/m³, with: 10 mg/m³: NOAEC, ((6 h/d)/(8 h/d)): correction factor for duration of exposure, (6.7 m³ (8h)/10 m³ (8h)): correction factor for light physical activity of workers.
- AF for dose response relationship:
- 1
- Justification:
- The dose response was unremarkable (no additional factor needed).
- AF for differences in duration of exposure:
- 2
- Justification:
- The most sensitive endpoint was observed in a sub-acute inhalation study. Of note, neurotoxic effects were already observed after 2 dosages in this study suggesting a non time dependend effect, in which TPP's toxicity doesn't increase gradually with exposure time. Therefore the AF was set at 2. The factor wasn't waived completely in order to account for remaining uncertainties since only 2 animals per dose were used in this study.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- The dose descriptor (NOAEC) was expressed as a concentration (ppm, mg/m³) and was thus scaled according to the allometric principle (no additional factor required).
- AF for other interspecies differences:
- 1
- Justification:
- The insensitivity of the rat in a 12-day inhalation study, in which aerosol from molten TPP was administered (Waritz, 1975), suggests that the dog study is representing a worst case scenario. Therefore, no additional interspecies factors were considered.
- AF for intraspecies differences:
- 5
- Justification:
- The default factor for worker was used.
- AF for the quality of the whole database:
- 1
- Justification:
- Two sub-acute studies on different species using different vehicles revealed varying NOAECs. According to a conservative approach the lower NOAEC was used for DNEL derivation. No additional factor is needed.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach of the DNEL derivation is already conservative (no further assessment factor needed).
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.07 mg/kg bw/day
- Most sensitive endpoint:
- neurotoxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 14
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The worker-DNEL long-term for dermal route - systemic is derived from the NOAEL of 1 mg/kg bw/d, obtained in the sub-acute oral study in dogs (M&T Chemicals, 1983) in which TPP was administered in oil. The NOAEL didn't need to be corrected since there were no deviations in absorption rate (100%) and exposure conditions (5 days/per week) between the worker (default values) and the laboratory animal.
- AF for dose response relationship:
- 1
- Justification:
- The dose response was unremarkable (no additional factor needed).
- AF for differences in duration of exposure:
- 2
- Justification:
- The most sensitive endpoint was observed in a sub-acute oral study. Of note, neurotoxic effects were already observed after 2 dosages in this study suggesting a non time dependend effect, in which TPP's toxicity doesn't increase gradually with exposure time. Therefore the AF was set at 2. The factor wasn't waived completely in order to account for remaining uncertainties since only 2 animals per dose were used in this study.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- The default allometric scaling factor for the differences between dogs and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- The insensitivity of the rat towards neurotoxic effects in a 90-day oral study, in which a water based vehicle was used (BASF, 2002), suggests that the dog study is representing a worst case scenario. Therefore, no additional interspecies factors were considered.
- AF for intraspecies differences:
- 5
- Justification:
- The default factor for worker was used.
- AF for the quality of the whole database:
- 1
- Justification:
- No repeated-dose study for the dermal route was available. However, sub-acute oral and inhalation studies and a sub-chronic oral study on different species using different vehicles were available for route-to-route extrapolation. Similar DNELs were calculated from all three studies. No additional factor is needed.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach of the DNEL derivation is already conservative (no further assessment factor needed).
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Conclusions from existing experimental data for DNEL settings
a) Local effects after short term and long term exposure
A DNEL derivation of local effects after inhalation exposure is not required since TPP does not cause respiratory irritation. Only weak indications of respiratory irritation were documented in one single study (Waritz, 1975). The authors observed salivation, lacrimation, dyspnea and red ears as the only adverse effects during a sub-acute inhalation study on in which an aerosol of molten TPP of approx. 2400
mg/m³ was administered to 6 rats for 12 days and concluded TPP to cause slight respiratory irritation. In this publication, however, neither the incidence nor time dependence or reversibility of effects was given and no histological findings on the respiratory tract were reported although a histological examination was conducted. Moreover no such findings were reported in a sub-acute study on dogs in which an xylene-based TPP aerosol was tested (M&T Chemicals, 1975) up to 20 mg/m³. Therefore, TPP is not expected to cause respiratory irritation.
The risk arising from TPP's skin sensitising (Category 1B) and eye damaging (Category 1) potential can only be addressed qualitatively due to the lack of suitable quantitative data.
b) Systemic effects after chronic exposure
The most relevant sub-acute and sub-chronic data which need to be considered regarding DNEL derivation for systemic toxicity after long-term exposure to DMAC are summarized in the Table below.
Table: Toxicity data relevant for DNEL (systemic, long-term exposure) derivation
Application route |
Study type (reference) |
NOAEL/NOAEC |
Inhalation |
Sub-acute toxicity study in dogs (whole body exposure, 28d, xylene-based aerosol; M&T Chemicals, 1983) |
10 mg/m³ |
Oral |
Sub-chronic toxicity study in rats (gavage, water-based vehicle; BASF, 2002) |
6 mg/kg bw/day |
Sub-acute toxicity study in dogs (gavage, oil-based vehicle; M&T Chemicals, 1983) |
1 mg/kg bw/day |
The conservative NOAEC of 10 mg/m³ determined in the sub-acute inhalation study in dogs (xylene-based aersosol) was much lower than the NOAEC of 2400 mg/m³ determined in the sub-acute inhalation study in rats (aerosol from molten substance). This lower value was selected as starting point for worker DNEL (inhalation, systemic, long-term) derivation. Since, it is expected that the dog study using a solvent-based vehicle represents the worst-case scenario, the default assessment factor for interspecies factor (remaining differences) of 2.5 was reduced to 1.
No experimental data on the dermal route were available as starting point for the derivation of a worker DNEL (dermal, systemic, long-term). Extrapolation of the dog sub-acute oral NOAEL of 1 mg/kg bw/d (M&T Chemicals, 1983) yielded a DNEL of 0.07 mg/kg bw/d applying a factor of 2 for exposure duration, 1.4 for allometric scaling from dog to human and a intraspecies factor of 5 for workers. The same DNEL was calculated when the dog sub-acute inhalation NOAEL of 10 mg/m³ (M&T Chemicals, 1983) was used as starting point considering the 6-h breathing volume of 0.1008 m³/kg bw for the dog and applying the above mentioned assessment factors. Equally, the rat sub-chronic NOAEL of 6 mg/kg bw/d (BASF, 2002) yields a comparable DNEL of 0.08 mg/kg bw/d considering a factor of 7/5 to account for differences in exposure days between rat and worker and applying a assessment factors of 2 for exposure duration, 4 for allometric scaling from rat to human, 2.5 for remaining interspecies differences and a intraspecies factor of 5 for workers. Thus, the selection of the sub-acute oral NOAEL of 1 mg/kg bw/d in the dog (M&T Chemicals, 1983) as starting point for worker DNEL (dermal, long-term) derivation is justified.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.01 mg/kg bw/day
- Most sensitive endpoint:
- neurotoxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 28
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 0.7 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The general population-DNEL long-term for oral route - systemic is derived from the NOAEL of 1 mg/kg bw/d, obtained in the sub-acute oral study in dogs (M&T Chemicals, 1983) in which TPP was administered in oil. The NOAELcorr is calculated as follows: NOAELcorr = 1 mg/kg bw/d*((5 d/wk)/(7 d/wk)) = 0.7 mg/kg bw/d.
- AF for dose response relationship:
- 1
- Justification:
- The dose response was unremarkable (no additional factor needed).
- AF for differences in duration of exposure:
- 2
- Justification:
- The most sensitive endpoint was observed in a sub-acute oral study. Of note, neurotoxic effects were already observed after 2 dosages in this study suggesting a non time dependend effect, in which TPP's toxicity doesn't increase gradually with exposure time. Therefore the AF was set at 2. The factor wasn't waived completely in order to account for remaining uncertainties since only 2 animals per dose were used in this study.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- The default allometric scaling factor for the differences between dogs and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- The insensitivity of the rat towards neurotoxic effects in a 90-day oral study, in which a water based vehicle was used (BASF, 2002), suggests that the dog study is representing a worst case scenario. Therefore, no additional interspecies factors were considered.
- AF for intraspecies differences:
- 10
- Justification:
- The default factor for general population was used.
- AF for the quality of the whole database:
- 1
- Justification:
- Sub-acute and a sub-chronic oral studies on different species using different vehicles revealed comparable NOAELs. Similar DNELs were calculated from all three studies. No additional factor is needed.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach of the DNEL derivation is already conservative (no further assessment factor needed).
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Additional information - General Population
No consumer uses were identified. The general population does not get in contact with the substance. Therefore, in accordance with the REACH legislation (regulation (EC) No 1907/2006, Annex I, 1.4.1), no DNEL has to be derived for the general population.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.